Japanese Research Finds Tamiflu And Relenza Early Administration Reduces Fever Symptoms
This article was originally published in PharmAsia News
Executive Summary
A research study released by Japan's National Institute of Infectious Disease found that patients affected with new strains of H1N1 flu virus who received earlier administration of flu drugs such as Tamiflu (oseltamivir) or Relenza(zanamivir) had shorter periods of fever symptoms. Conducted in Osaka with 171 patients, the research found that on average patients treated within 24 hours of infection had fever systems that lasted 1.9 days; those treated after one day had a fever for 2.5 days and those who were treated between two to five days had a fever for 3-4 days. (Click here for more - Japanese language